We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 1.20% | 4.20 | 4.10 | 4.30 | 4.20 | 4.00 | 4.15 | 2,025,708 | 16:00:34 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.00 | 22.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/5/2024 10:03 | Ramping Rubbish. -------------------- TARGET Eden Research plc (LON:EDEN) SP ZERO PENCE (0.000000p) | neutralpov | |
11/5/2024 06:41 | 📍Great success of participation in the "horticultural crops platform" that Certis Belchim organized on April 24th in Sicily, in Acate (RG) 💥New multi-thematic sharing formula in collaboration with SAGEA Group and DD Trade Europe Danilo Deluca, to present the various innovative defense solutions dedicated to greenhouse horticultural crops. 💥Extensive interest on the part of technicians and farmers for the different solutions on the control of two important adversities such as root-knot nematodes and powdery mildew. 🎤 colleagues Maria Dimartino, Franco Riva and Alberto Santori explained the efficacy of Problad against powdery mildew in tomatoes and peppers. Problad is an innovative fungicide of natural origin, soon to be registered, based on aqueous extract of sweet lupin seeds; its active component, BLAD, is a protein with strong fungicidal activity with an innovative mechanism of action. Its effectiveness, highlighted in the tests illustrated, and the wide range of action have impressed the participants who are waiting for its registration in order to be able to shape new, effective and more sustainable defense strategies. The efficacy results of the nematicide strategy based on Cedroz™ and Nemaclean, the soon-to-be-registere Cedroz™, Nemaclean and Leavly+ ® represent a new reference solution in the control strategy of root-knot nematodes that ensures full efficacy throughout the entire crop development cycle. 🥇Innovation comes from here! When modern horticulture requires innovations, Certis Belchim provides the right solutions! | supersonico | |
10/5/2024 22:17 | blip; Symrise AG | supersonico | |
10/5/2024 21:58 | Mugavero Fertilizzanti With an ever-increasing demand for ZERO RESIDUE products, the large-scale retail trade led us to think of a solution in collaboration with Certis Belchim IT We realised, in the OP Palumbo Più Farm (Italy) a demonstration day to contrast #nematodes. The idea was to place the #CEDROZ product alongside our #BATTIRIA coating and BATTIRIA fluid products. The result was very satisfying, a special thanks to all the technicians and organisers of Certis Belchim. | supersonico | |
10/5/2024 17:50 | Investing, if it is Syngenta global then 1) That's all your eggs in one basket which. I think Syngenta are part of the picture likely part of more than one egg basket .. a big one.. of the 10+ and part of the Global deal that Abrey mentioned but a closer partner like Corteva are with Ecovelex. 2) Means Eden should have very specific demands and I hope they do. 3) A contract that gives Eden control, not Syngenta Sounds from the Abrey 'Dearth' comment and the numerous interested parties that Eden should have good leverage. 4) With a significant upfront payment and I'd hope so from all 10. 5) Detailed timelines for regulatory submission in all territories. That sort of inthecoming would be great 6) with minimum guaranteed order for each territory on regulatory approval. Given the Dearth I imagine this should be easy to agree upon. 7) so that Eden can have some certainty around revenue, but also have an exit clause if Syngenta don't meet the above and no doubt, much more. I think Syngenta are a significant player but with 10 others in negotiations and what sounds like industry product vacuum both Eden and Syngenta would want to avoid this outcome. | supersonico | |
10/5/2024 16:27 | Re "article" just posted by "Tricky". Crawl back into your hole, you lying paid ramper. You own not a single share in this pariah of the AIM, and you hold those who do in contempt. Filth, pure filth. | neutralpov | |
10/5/2024 16:22 | Super, if it is Syngenta global then 1) That's all your eggs in one basket which 2) Means Eden should have very specific demands and 3) A contract that gives Eden control, not Syngenta 4) With a significant upfront payment and 5) Detailed timelines for regulatory submission in all territories 6) with minimum guaranteed order for each territory on regulatory approval so that Eden can have some certainty around revenue, but also have an exit clause if Syngenta don't meet the above and no doubt, much more | investingisatrickygame | |
10/5/2024 15:56 | Is it true that one of the major private wumpfarts in this dogstock has topped himself? | neutralpov | |
10/5/2024 09:04 | ravenna23, this is so amusing. It is like peering into a kooky religious cult. You know, where all the deluded fools think they are being revealed great truths. While Trickies are there herding and fleecing them financially and the cult leader gets to b*gger the nubile teenage girls. :D Yes, it is even more amusing for them, I concede. (chuckle and muggasoup) | neutralpov | |
10/5/2024 00:35 | My Ponderings to date; Will the Syngenta RNS have.. Syngenta..Seed Treatment.. or Syngenta..Fungicide. or Syngenta ..Insecticide... Global In the title? | supersonico | |
09/5/2024 14:01 | Best guess is best ignored given his habit of being wrong all the time. | supersonico | |
09/5/2024 13:34 | Do any bulls here see any merit in that view of a Corteve Exploitsble ?Or does it man they might have to take us? | alchemy | |
09/5/2024 12:37 | Sorry that should be leech, damn spell check@ | ravenna23 | |
09/5/2024 12:32 | This share is going nowhere, it is OWNED by Corteva. They will get any money to be made by Edens IP. All you are doing as a shareholder is paying for the executive pension fund. Anyone who took my tip on 23rd April re cancer firm Immutep would be up 30%. Instead you stick with a bunch of leaches and are down with Eden. Do the math guys. TRICKY is a boiler room operator. | ravenna23 | |
09/5/2024 11:02 | Everyone tip toes around forward looking statements. Well we've had the first quarter . Was it good?I think Smith is smart considered and is strategically on course . The but concerns Adrenalin . Could he not have a double espresso before one of his media opportunities? Atb folks | alchemy | |
09/5/2024 10:56 | 'Maybe it’s being set up for being beaten' Smashed more likely imo. | supersonico | |
09/5/2024 10:46 | That's your view and thanks for your patience in typing it out. Sales, Margin, Overheads, and Cash are the key parameters and yes Sales leads the pack, Sorry to bang the same drum but the estimate of only £5mill for 24 is disappointing. Maybe it's being set up for being beaten. Deja vu of previously deja viewed is my current concern | alchemy | |
09/5/2024 10:35 | Nice to see this Syngenta fella supporting the Supersonico Wild guesses by being the first to like the planned Eden PR on Linked-in. Humair Tariq Portfolio Manager Biologicals, Insect Control and Seed Treatment Results & Data-Driven Marketing Expert | Global Portfolio Management @ Syngenta I Catapulting Businesses to New Heights | Unmatched NPI Prowess I Mastering Digital Capabilities I Entrepreneur I Founder@Barbell Studioz Syngenta 11 yrs 8 On-site Portfolio Manager Biologicals, Insect Control and Seed TreatmentPortfolio Manager Biologicals, Insect Control and Seed Treatment Full-timeFull-time May 2022 - Mar 2024 · 1 yr 11 mosMay 2022 to Mar 2024 · 1 yr 11 mos United KingdomUnited Kingdom Introduced Nuello® iN, Syngenta's inaugural biological seed treatment, resulting in an additional business of £0.6 m. Initiated and primed the portfolio pipeline, ensuring the introduction of 2 products / year until 2026 to expand portfolio range. Leveraged end-to-end NPI for the successful launch of Vixeran®, a foliar bacterial endophyte, adding £1 m to business. Successfully managed PLCM of portfolio by introducing fighter brands to maintain 41% market share. Effectively deterred generic market entry in cereal seed treatment through strategic pricing and commercial incentives. Established a technical asset library for NUE technologies, utilized by the sales team for capability development. Managed CRD and HCP collaboration for EA of CP & ST products, yielding GBP 0.3 million in additional revenue. Brought campaign efficiencies and cost savings by taking data-driven decisions using Remote Sensing Technologies and GIS system. | supersonico | |
09/5/2024 10:30 | Not if you have seen his posts for the last few years. He always seems to have a bit of inside info, but only of the positive spin kind. In the meantime Eden has cratered. Tricky by name tricky by nature. | ravenna23 | |
09/5/2024 09:50 | That's a bit steep. | alchemy | |
09/5/2024 09:33 | Tricky, you are as full of BS as the directors. The CEO and CFO are so delusional that they believe their presentation will shore up the price. Hilarious. There is only one thing that will stop the rot and that is actual volume sales. Still no sign of that. I'm sure that everyone who contributed to the latest capital raising is ecstatic with the company's performance. Go back to your boiler room you shameful toad. | ravenna23 | |
09/5/2024 09:17 | Proactive video released today | investingisatrickygame | |
09/5/2024 09:02 | Yes I don't want confirmation of the route confirmation again. | alchemy | |
09/5/2024 07:08 | I hope between now and then that they have something else to add to the mix as if not this looks imo like a waste of time given what is publicly available in the PR they have already done over the last year. Investor Presentation via Investor Meet Company. | supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions